A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
A Study of Pembrolizumab in Patients With Relapsed Or Metastatic Osteosarcoma Not Eligible for Curative Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Participants With Selected Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) Blockade
- Status
- COMPLETED
- Phase
- PHASE1
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Study of Guadecitabine/ASTX727 and Pembrolizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE3
A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC
- Status
- TERMINATED
- Phase
- PHASE1
HDCRT Plus Pembrolizumab in Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron
- Status
- TERMINATED
- Phase
- PHASE2
Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- EARLY_PHASE1